向華 徐繼宗 湯加兵 蔡駿 李可可 鄭永強



【摘要】 目的:對比腹腔鏡和開腹再次肝切除術治療復發性肝細胞癌的效果及對肝功能的影響。方法:選取2018年12月-2019年12月經筆者所在醫院確診的100例復發性肝細胞癌患者。根據手術方式的不同將其分為對照組和研究組,每組50例。對照組行開腹再次肝切除術,研究組在腹腔鏡下行再次肝切除術。比較兩組手術指標、治療前后肝功能指標、術后不同時間VAS評分、治療前后免疫功能指標水平。結果:研究組手術時間、術中出血量、排氣時間、下床活動時間均優于對照組,差異有統計學意義(P<0.05)。治療前,兩組肝功能指標比較差異均無統計學意義(P>0.05);治療后兩組肝功能指標均有所改善,且研究組改善程度優于對照組,差異有統計學意義(P<0.05)。研究組術后1、3、7 d的VAS評分均低于對照組,差異有統計學意義(P<0.05)。治療前,兩組免疫功能指標比較差異均無統計學意義(P>0.05);治療后兩組免疫功能指標均有所改善,且研究組改善程度優于對照組,差異有統計學意義(P<0.05)。結論:采用腹腔鏡下再次肝切除術治療復發性肝細胞癌的效果較開腹手術更為理想,患者臨床指標改善效果更佳,因此可在臨床推廣應用。
【關鍵詞】 復發性肝細胞癌 肝切除術 腹腔鏡 開腹切除 肝功能
doi:10.14033/j.cnki.cfmr.2020.27.054 文獻標識碼 B 文章編號 1674-6805(2020)27-0-03
[Abstract] Objective: To compare the effect of laparoscopic and open rehepatectomy in the treatment of recurrent hepatocellular carcinoma and its effect on liver function. Method: A total of 100 patients with recurrent hepatocellular carcinoma diagnosed in our hospital from December 2018 to December 2019 were selected. They were divided into the control group and the study group according to the different surgical methods, with 50 cases in each group. The control group underwent open rehepatectomy, while the study group underwent laparoscopic rehepatectomy. The operation indexes, liver function indexes before and after treatment, VAS scores at different times after surgery and immune function indexes levels before and after treatment were compared between the two groups. Result: The operation time, intraoperative bleeding volume, exhaust time, and time of getting out of bed activity in the study group were all better than those in the control group, the differences were statistically significant (P<0.05). Before treatment, there were no statistically significant differences in liver function indexes between the two groups (P>0.05). After treatment, liver function indexes of the two groups were improved, and the improvement degree of the study group was better than that of the control group, the differences were statistically significant (P<0.05). The VAS scores of the study group at 1, 3 and 7 days after surgery were lower than those of the control group, the differences were statistically significant (P<0.05). Before treatment, there were no significant differences in immune function indexes between the two groups (P>0.05). After treatment, the immune function indexes of the two groups were improved, and the improvement degree of the study group was better than that of the control group, the differences were statistically significant (P<0.05). Conclusion: The effect of laparoscopic rehepatectomy in the treatment of recurrent hepatocellular carcinoma is better than that of open surgery, and the improvement of clinical indexes is better, so it can be widely used in clinical practice.
本文選取100例復發性肝細胞癌患者,對照組以開腹肝臟再切除術治療,研究組以腹腔鏡下肝臟再切除術進行治療,結果顯示,研究組手術指標、肝功能指標、免疫功能指標、疼痛程度均優于對照組。這是因為相比于開腹手術而言,腹腔鏡手術有以下4個優點:(1)氣腹的建立增加手術視野,為腹腔粘連的分離提供了廣闊的術野;(2)通過操作小切口進行腹腔鏡及器械方向的轉變,避免了非術區粘連;(3)氣腹的建立可壓迫小血管,減少出血,同時通過電凝止血及直線切割閉合器,進一步降低出血量;(4)腹腔鏡下手術切口小,降低了對腹壁神經的刺激及損傷[12-13]。
綜上所述,腹腔鏡下再次肝切除術治療復發性肝細胞癌的效果更為理想,患者臨床指標改善效果更佳,因此可在臨床推廣應用。
參考文獻
[1]李春麗,董巧云,侯麗,等.二次切除手術與經皮射頻消融治療切除后復發性肝細胞肝癌的臨床療效和預后分析[J].中國醫學裝備,2019,16(12):47-51.
[2]陳雪芳,謝浩榮,王愷,等.腹腔鏡與開腹再次肝切除術治療復發性肝細胞癌的安全性及療效對比[J].中華肝膽外科雜志,2019,25(3):175-178.
[3]穆森茂,李德宇.腹腔鏡肝切除術中轉開腹時機把握[J].肝膽外科雜志,2019,27(4):244-246.
[4]江旭,李慧,楊繼金,等.常規TACE術中DSA診斷肝細胞癌切除術后3個月內復發[J].中國介入影像與治療學,2018,15(7):387-391.
[5]黃永杰,吳德全,苑俊輝.老年肝細胞癌患者的治療現狀[J].臨床肝膽病雜志,2018,34(6):1313-1317.
[6]張磊,陳亞進.腹腔鏡手術治療復發性肝癌的價值及評價[J].中國實用外科雜志,2019,39(10):1037-1040.
[7]蔡秀軍,金仁安.復發性肝癌治療方式合理選擇[J].中國實用外科雜志,2019,39(10):1015-1020.
[8]汪珍光,周偉平.復發性肝癌診治的幾個焦點問題[J].中國實用外科雜志,2019,39(10):1027-1030.
[9]張福鑫,鄭揚,涂攀.完全腹腔鏡術治療開腹術后復發性肝細胞肝癌的療效、安全性及預后分析[J/OL].中華普外科手術學雜志:電子版,2019,13(3):244-246.
[10]陳建勛.完全腹腔鏡下與開腹手術治療復發性肝癌的療效及CCL18水平變化比較[J/OL].中華普外科手術學雜志:電子版,2019,13(3):247-249.
[11]尹井賀,申建中,尚寶劍.完全腹腔鏡切除術治療復發性肝癌的可行性及對免疫功能影響的臨床研究[J].癌癥進展,2019,17(5):545-548.
[12]劉嘉龍,黃登,曹利,等.腹腔鏡肝切除術和射頻消融術治療復發性肝癌的前瞻性隨機對照研究(中期隨訪分析)[J].第三軍醫大學學報,2019,41(5):467-472.
[13]廖佳建,江斌,李猛.腹腔鏡肝切除在復發性肝癌治療中的應用[J].現代腫瘤醫學,2017,25(10):1578-1580.
(收稿日期:2020-03-26) (本文編輯:桑茹南)